EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HIV-2 glycoproteins upregulate microRNAs 25 and 93 to counter the MARCH1 antiviral effect in macrophages

Robert Lodge iD, Dorota Kmiec iD, Frank Kirchhoff iD, Éric A Cohen iD

Journal of Virology · 23.12.2025 · 99 (12)

DOI: 10.1128/jvi.01663-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 23.12.2025. Verfasst von Robert Lodge und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Retrovirology, Institut de recherches cliniques de Montréal (IRCM), Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: MicroRNAs, HIV-2, Macrophages, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The membrane-associated E3 ubiquitin ligase MARCH1 restricts HIV-1 infectivity by decreasing the amount of cell surface Env glycoproteins and their incorporation into progeny virions. To circumvent this restriction, the HIV-1 accessory protein Vpu increases the levels of microRNAs 25 and 93 that target MARCH1 RNA. Mechanistically, Vpu interaction with the β-TrCP substrate receptor of the SCF β-TrCP E3 ligase, a host partner critical for Vpu functions, leads to a stabilization of SCF β-TrCP cellular targets, such as β-catenin, which drives transcription of the MARCH1 -targeting microRNAs. Here, we show that HIV-2 and SIVmac239, which do not encode for Vpu, also upregulate microRNAs 25 and 93 in macrophages, as well as in the macrophage-like THP-1 cell line model. Inhibiting the MARCH1 mRNA-targeting microRNAs impaired HIV-2 infectivity and reduced viral spread in macrophages. While none of the HIV-2 accessory proteins upregulated microRNAs 25 and 93, the Env glycoproteins of HIV-2 and SIVmac239 were sufficient to induce their expression. Depletion of β-TrCP-1 and 2 or pharmacological inhibition of β-catenin in THP-1 cells revealed that Env-mediated upregulation of microRNA 25 and 93 is β-TrCP dependent and involves β-catenin, similar to Vpu. Our findings highlight a new function of the HIV-2 and SIVmac239 glycoproteins as inducers of microRNAs 25 and 93 that counteract MARCH1 and potentiate viral replication in macrophages. IMPORTANCE Macrophage infection by primate lentiviruses (HIV-1, HIV-2, and SIV) is restricted by, among other host factors, the MARCH1 membrane-associated protein. HIV-1 circumvents the MARCH1 restriction by using its accessory protein Vpu, which induces the anti-MARCH1 microRNAs 25 and 93. HIV-2 has infected up to 2 million people so far, and SIV infection is indispensable for animal models of primate lentivirus pathogenesis. These two lentiviruses do not have a vpu gene, but also target MARCH1 by inducing the same microRNAs. We have now determined that the HIV-2 and SIV antagonists of MARCH1 are their envelope glycoproteins. The HIV-2 and SIVmac239 Env glycoproteins upregulate microRNAs 25 and 93 by disrupting the β-catenin pathway, similar to HIV-1 Vpu. The fact that different lentiviruses have developed a similar strategy using microRNAs to counter MARCH1 antiviral activity emphasizes its relevance in the antiviral host response, as well as a target in antiviral therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsHIV-2MacrophagesUbiquitin-Protein LigasesHumansSimian Immunodeficiency VirusViral Regulatory and Accessory ProteinsHIV-1beta CateninAnimalsTHP-1 CellsHIV InfectionsUp-RegulationCell LineVirus ReplicationHost-Pathogen Interactions

Stichwörter der Autor:innen

Env glycoproteinHIV-2MARCH1SIVTHP-1beta-TrCPbeta-cateninhost restriction factormacrophagemicroRNA

Substanzen

MicroRNAsUbiquitin-Protein LigasesViral Regulatory and Accessory Proteinsbeta Catenin

Autor:innen und Institutionen

  • Laboratory of Human Retrovirology, Institut de recherches cliniques de Montréal (IRCM), Montreal, Quebec, Canada.
  • Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
  • Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, Quebec, Canada.

ORCID-Profile: Robert Lodge, Dorota Kmiec, Frank Kirchhoff, Éric A Cohen

Förderung

  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Lodge, R., Kmiec, D., Kirchhoff, F., & Cohen, É. A. (2025). HIV-2 glycoproteins upregulate microRNAs 25 and 93 to counter the MARCH1 antiviral effect in macrophages. Journal of Virology, 99(12). https://doi.org/10.1128/jvi.01663-25

Vancouver

Lodge R, Kmiec D, Kirchhoff F, Cohen ÉA. HIV-2 glycoproteins upregulate microRNAs 25 and 93 to counter the MARCH1 antiviral effect in macrophages. Journal of Virology. 2025;99(12). doi:10.1128/jvi.01663-25

BibTeX
@article{Lodge2025,
  author = {Lodge, Robert and Kmiec, Dorota and Kirchhoff, Frank and Cohen, Éric A},
  title = {HIV-2 glycoproteins upregulate microRNAs 25 and 93 to counter the MARCH1 antiviral effect in macrophages},
  journal = {Journal of Virology},
  year = {2025},
  volume = {99},
  number = {12},
  doi = {10.1128/jvi.01663-25}
}
Kostenlos starten →